---
title: IREN (IREN) — Wall Street analysts' targets, grades and estimates
canonical: https://sweetvaluelab.com/stocks/iren/analysts
ticker: IREN
as_of: 2026-11-02
sector: Technology
---
# IREN (IREN) — Wall Street analysts

5 firms published a price target for IREN in the last 90 days. Counting each firm once, at its latest, the median target is $85.00, 255% above the last close of $23.95 (Oct 30, 2026); the lowest is $40.00 and the highest $100.00.

These are the analysts' figures, quoted, not this site's. The site's own model value for IREN is on the valuation page: https://sweetvaluelab.com/stocks/iren/valuation.

## At a glance

| Figure | Value |
| --- | ---: |
| Median target (each firm's latest, last 90 days) | $85.00 |
| Median target vs last close | +255% |
| Firms with a target, last 90 days | 5 |
| Lowest – highest target | $40.00 – $100.00 |
| Current grades of 8 firms: positive / neutral / negative | 8 / 0 / 0 |
| Upgrades / downgrades, last 12 months | 3 / 0 |
| Consensus revenue growth, next 3 fiscal years | +164% a year |

## Each firm's latest target (last 90 days)

Newest first. Change is against the same firm's previous target; the last two columns are the target against the close on the day it was published and against the last close.

| Date | Firm | Target | Previous | Change | Vs price then | Vs price now | Report |
| --- | --- | ---: | ---: | ---: | ---: | ---: | --- |
| 2026-09-21 | Rothschild & Co Redburn | $40.00 | — | — | −14% | +67% | https://thefly.com/ajax/news_get.php?id=4428157 |
| 2026-09-18 | Northland Securities | $99.00 | — | — | +128% | +313% | https://thefly.com/ajax/news_get.php?id=4427711 |
| 2026-09-14 | BTIG | $80.00 | — | — | +83% | +234% | https://www.streetinsider.com/Analyst+Comments/BTIG+Reiterates+Buy+Rating+on+IREN+Ltd.+%28IREN%29/27054690.html |
| 2026-08-28 | Compass Point | $85.00 | $105.00 | −19% | +128% | +255% | https://www.streetinsider.com/Analyst+Comments/IREN+Ltd.+%28IREN%29+PT+Lowered+to+%2485+at+Compass+Point/26993089.html |
| 2026-08-13 | Bernstein | $100.00 | $96.00 | +4% | +129% | +318% | https://www.streetinsider.com/Analyst+Comments/Bernstein+SocGen+Group+Reiterates+Outperform+Rating+on+IREN+Ltd.+%28IREN%29/26915898.html |

## Current grades (each firm's latest, last 12 months)

| As of | Firm | Grade |
| --- | --- | --- |
| 2026-10-30 | B. Riley | “Buy” |
| 2026-09-14 | BTIG | “Buy” |
| 2026-09-14 | J.P. Morgan | “Overweight” |
| 2026-09-02 | Freedom Capital Markets | “Buy” |
| 2026-08-28 | Canaccord Genuity | “Buy” |
| 2026-08-28 | Macquarie | “Outperform” |
| 2026-08-28 | H.C. Wainwright | “Buy” |
| 2026-08-28 | Cantor Fitzgerald | “Overweight” |

## Grade changes (last 24 months)

| Date | Firm | From | To | Action |
| --- | --- | --- | --- | --- |
| 2026-09-14 | J.P. Morgan | “Underweight” | “Overweight” | upgrade |
| 2026-07-06 | Freedom Capital Markets | “Hold” | “Buy” | upgrade |
| 2026-01-13 | H.C. Wainwright | “Sell” | “Buy” | upgrade |
| 2025-10-29 | H.C. Wainwright | “Buy” | “Sell” | downgrade |
| 2025-09-26 | J.P. Morgan | “Neutral” | “Underweight” | downgrade |
| 2025-09-02 | Jones Trading | “Buy” | “Hold” | downgrade |
| 2025-07-28 | J.P. Morgan | “Overweight” | “Neutral” | downgrade |
| 2025-03-13 | J.P. Morgan | “Neutral” | “Overweight” | upgrade |
| 2024-12-10 | J.P. Morgan | “Overweight” | “Neutral” | downgrade |

8 older changes are listed on the page.

## Consensus estimates by fiscal year

A reported year shows the company's revenue and GAAP diluted EPS with the consensus beside it; a later year shows the consensus average and its range. The analysts' EPS usually leaves items such as stock compensation out, so reported and estimated EPS are not like for like.

| Fiscal year | Status | Revenue | YoY | EPS | YoY | Consensus revenue | Consensus EPS | Analysts |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| 2023 | reported | $75.5M | +28% | -$3.14 | — | $76.1M (reported −1% vs it) | -$3.47 | 6 |
| 2024 | reported | $187.2M | +148% | -$0.29 | — | $208.8M (reported −10% vs it) | -$0.58 | 3 |
| 2025 | reported | $501.0M | +168% | $0.39 | — | $510.5M (reported −2% vs it) | $0.07 | 7 |
| 2026 | reported | $707.0M | +41% | -$2.22 | −669% | $702.0M (reported +1% vs it) | -$0.69 | 12 |
| 2027 | estimate | $2.7B | +284% | -$1.95 | — | $2.5B – $2.8B | -$13.05 – $15.56 | 12 |
| 2028 | estimate | $7.3B | +168% | -$0.19 | — | $4.4B – $11.4B | -$57.28 – $42.42 | 10 |
| 2029 | estimate | $13.1B | +80% | $3.41 | — | $7.8B – $19.9B | $1.50 – $5.19 | 4 |
| 2030 | estimate | $25.3B | +94% | $1.33 | −61% | $15.1B – $38.5B | $0.64 – $2.23 | 2 |

---

Source: https://sweetvaluelab.com/stocks/iren/analysts (SweetValueLab, free, no account). Targets, grades and estimates are the analysts' own, quoted from Financial Modeling Prep's analyst feeds; reported figures from the company's statements. Research and educational data, not investment advice; nothing here is a recommendation to buy, sell or hold any security.